Cadila Healthcare Recovers after Falling 10%
 

The US Food and Drug Administration's observation letter could result in approval delays at a time when the Cadila's domestic revenues have been impacted by price controls.http://ndtv.com.feedsportal.com/c/33...f4/sc/1/mf.gif


http://da.feedsportal.com/r/20436605.../1/rc/1/rc.img
http://da.feedsportal.com/r/20436605.../1/rc/2/rc.img
http://da.feedsportal.com/r/20436605.../1/rc/3/rc.img

http://da.feedsportal.com/r/20436605...f4/sc/1/a2.imghttp://pi.feedsportal.com/r/20436605...4/sc/1/a2t.img

أكثر...